Adverse Effects

Brain Cancer

HER2-Positive Breast Cancer

Triple-Negative Breast Cancer

Breast Cancer

Colorectal Cancer

Esophageal Cancer

Gastric Cancer

Liver Cancer

Pancreatic Cancer

Gastrointestinal Cancer

Bladder Cancer

Kidney Cancer

Prostate Cancer

Genitourinary Cancers

Cervical Cancer

Endometrial Cancer

Ovarian Cancer

Gynecologic Cancers

Head & Neck Cancer

Multiple Myeloma

Myelodysplastic Syndromes

Myeloproliferative Neoplasms

Hematologic Oncology

Vaccines

Infection

Leukemia

Non-Small Cell Lung Cancer (NSCLC)

Small Cell Lung Cancer (SCLC)

Lung Cancer

Lymphoma

Neuroendocrine Tumors

Oncology

Pediatric Cancers

Radiation Oncology

Sarcoma

Screening

Skin Cancer & Melanoma

Surgery

Thyroid Cancer

News

Global Bulletin

All News

FDA Approval Alert

Women in Oncology

Media

Expert Interviews

Around the Practice

Between the Lines

Face Off

From All Angles

Meeting of the Minds

OncView

Podcasts

Training Academy

Treatment Algorithms with the Oncology Brothers

Conferences

Publications

All Journals

Editorial Board

For Authors

Year in Review

Events

Frontline Forum

Satellite Sessions

CME/CE

Resources

Awareness Month

Interactive Tools

Nurse Practitioners/Physician's Assistants

Partners

Career Center

Subscribe

CancerNetwork is home to the journal Oncology & provides insights on the screening, early detection, diagnosis, treatment and prevention of cancers.

About

Advertise

CureToday.com

OncLive.com

OncNursingNews.com

TargetedOnc.com

Editorial

Contact

Terms and Conditions

Privacy

Do Not Sell My Personal Information

CancerNetwork - Oncology News and Clinical Expertise

Facebook

LinkedIn

Spotlight

Clinical

Genitourinary Cancer

Gynecologic Cancer

Hematology

Skin Cancer

1rem

Vinay K. Puduvalli, MD, explores recent advances in glioma classification and treatment, discussing the impact of new WHO guidelines, molecular markers, clinical trials, and emerging therapies like IDH inhibitors on patient care strategies, while identifying persisting challenges and future research priorities in neuro-oncology.

Evolving Landscape of Glioma: A Focus on IDH-Mutant Gliomas

Treatment of NSCLC: Best Practices from the University of Kansas Cancer Center and Satellites

Experts on multiple myeloma review recent data updates and discuss how they work with satellite clinics and apply evidence into clinical practice.

Treatment of Multiple Myeloma: Best Practices from UPMC and Satellites

Expert panelists from the Levine Cancer Institute and satellite clinics review recent updates in the treatment of multiple myeloma and reflect on how they apply evidence to their clinical practice. 

Treatment of Multiple Myeloma: Best Practices from Levine Cancer Institute and Satellites

Expert physicians from Ochsner Health reflect on how they apply evidence into clinical practice and work between the main campus and satellite clinics to improve patient outcomes in the setting of multiple myeloma.

Treatment of Multiple Myeloma: Best Practices from Ochsner Health and Satellites 

Experts from City of Hope reflect on the current treatment landscape of multiple myeloma and how clinical data are applied to their practice within the main campus and satellite institutions. 

Treatment of Multiple Myeloma: Best Practices from City of Hope and Satellites

Treatment of Multiple Myeloma: Best Practices from Yale Cancer Center and Satellites

A panel of expert physicians from satellite clinics of MD Anderson review recent updates in the treatment of multiple myeloma and discuss how emerging evidence is applied to their clinical practice.

Treatment of Multiple Myeloma: Best Practices from The MD Anderson Cancer Center and Satellites 